NVentures — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Quantinuum develops quantum computers and quantum software solutions for applications in drug discovery, healthcare, materials science, cybersecurity, and energy.
Deep TechEnterprise SoftwareQuantum ComputingBroomfield, US
Ilyas Khan(Chief Product Officer)Rajeeb Hazra(President and CEO)Avinash Palaniswamy(Chief Commercial Officer)Susan Schwamberger(Chief Human Resources Officer and SVP Operations)Jennifer Strabley(VP and General Manager, Compute Products)Waseem Shiraz(Senior VP Strategic Initiatives & Chief of Staff)
Inceptive builds foundation models of biological systems for drug discovery, specializing in sequence-based medicines like mRNA and peptides.
AI & Machine LearningBiotechMedical DevicesPalo Alto, US
Jakob Uszkoreit(Executive Officer, Director, Promoter)Kevin Heyries(Executive Officer)Diana Isabel Ajuria(Executive Officer)Do Soon Kim(Executive Officer)
BoardVijay S. Pande(Director)in
Luma Labs builds AI agents that generate, understand, and operate in the physical world, enabling creative teams to rapidly produce video, image, audio, and text content with unified general intelligence driving creative workflows.
AI & Machine LearningCreator EconomyMedia & EntertainmentPalo Alto, US
Amit Jain(Executive Officer, Director, Promoter)Sixian Yu(Executive Officer, Director, Promoter)
BoardDavid Beyer(Director)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.